Information for Vermont prescribers of prescription drugs
This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety. Please refer to each product's FDA-approved label and indication for further information.
The prices listed below are Average Wholesale Prices ("AWP") as established and made available to the public by a third-party publisher or as calculated from data made available to the public by a third-party publisher. The price paid by consumers may be higher or lower than the prices listed below. Information about AWP of these drugs is being provided to Vermont prescribers pursuant to Vermont law, to give you information about the relative prices of marketed drugs and other drugs in the same therapeutic class.
The prices listed here do not necessarily reflect price per dosage, price per course of treatment or the cost effectiveness, of all the products listed. For simplicity, only the smallest package sizes available for each product are included.
KALYDECO® (ivacaftor) Tablets
ORKAMBI® (lumacaftor/ivacaftor) Tablets
SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) Tablets
TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Tablets
ALYFTREK™ (vanzacaftor/tezacaftor/deutivacaftor) Tablets
Product Name | Manufacturer | NDC or UPC | PKG Size | Pack | Tab |
Marketed Products |
|
|
|
| |
KALYDECO® Oral Tablet 150 mg | Vertex Pharmaceuticals Incorporated | 51167-0200-01 | 56 EA | $31,855.20 | $568.84 |
ORKAMBI® Oral Tablet 100-125 mg | Vertex Pharmaceuticals Incorporated | 51167-0700-02 | 112 EA | $27,886.78 | $248.98 |
ORKAMBI® Oral Tablet 200-125 mg | Vertex Pharmaceuticals Incorporated | 51167-0809-01 | 112 EA | $27,886.78 | $248.98 |
SYMDEKO® Oral Tablet Therapy Pack 50-75 & 75 mg | Vertex Pharmaceuticals Incorporated | 51167-0113-01 | 56 EA | $29,860.75 | $533.22 |
SYMDEKO® Oral Tablet Therapy Pack 100-150 & 150 mg | Vertex Pharmaceuticals Incorporated | 51167-0661-01 | 56 EA | $29,860.75 | $533.22 |
TRIKAFTA® Oral Tablet Therapy Pack 100-50-75 & 150 mg | Vertex Pharmaceuticals Incorporated | 51167-0331-01 | 84 EA | $31,855.20 | $379.22 |
TRIKAFTA® Oral Tablet Therapy Pack 50-25-37.5 & 75 mg | Vertex Pharmaceuticals Incorporated | 51167-0106-02 | 84 EA | $31,855.20 | $379.22 |
ALYFTREK™ Oral Tablet Therapy Pack 10/50/125 mg | Vertex Pharmaceuticals Incorporated | 51167-0121-01 | 56 EA | $28,404.22 | $507.22 |
Other Products | |||||
n/a |
JOURNAVX™ (suzetrigine) Tablets
Product Name | Manufacturer | NDC or UPC | PKG Size | Pack | Tab |
Marketed Products |
|
|
|
| |
JOURNAVX™ (30-count bottle) | Vertex Pharmaceuticals Incorporated | 51167-0548-30 | 30 EA | $558.00 | $18.60 |
JOURNAVX™ (100-count bottle) | Vertex Pharmaceuticals Incorporated | 51167-0548-31 | 100 EA | $1,860.00 | $18.60 |
Other Products | |||||
n/a |
Medispan is the source of this information.
Disclosure effective date: January 2025.